Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Hepatocellular 6Neoplasm Metastasis 5Melanoma 3Cholangiocarcinoma 3Breast Neoplasms 3Sarcoma 2Osteosarcoma 2Liver Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unresectable Solid Tumors 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Retinoblastoma 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroblastoma 1Lung Neoplasms 1Liver Metastasis 1High-Burden Metastatic Solid Tumors 1Hepatoblastoma 1Gastric Cancer Metastatic to Liver 1Diabetes Mellitus, Insulin-Dependent, 12 1Desmoid Tumors 1Colonic Neoplasms 1

Interventions

aldesleukin 16Cyclophosphamide 14fludarabine phosphate 11Interleukin-2 11fludarabine 10Nivolumab 7pembrolizumab 5cemiplimab 5Ipilimumab 5Temozolomide 4Fluorouracil 4Aminolevulinic Acid 4sonidegib 3Surgical Procedures, Operative 3Radiotherapy 3zanolimumab 2trametinib 2talabostat 2montanide ISA 51 2dabrafenib 2Whole-Body Irradiation 2Tablets 2Semaxinib 2Radiation 2Petrolatum 2Peptides 2MART-1 Antigen 2Gefitinib 2Eflornithine 2Cisplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Skin Neoplasms × Cryosurgery × Clear all
NCT05779423 2026-05-19

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Massachusetts General Hospital

Phase 2 Recruiting
37 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡